Diabetes, Vol 43, Issue 5 730-733, Copyright © 1994 by American Diabetes Association

ARTICLES

Six mutations in the glucokinase gene identified in MODY by using a nonradioactive sensitive screening technique

J Hager, H Blanche, F Sun, NV Vaxillaire, W Poller, D Cohen, P Czernichow, G Velho, JJ Robert, N Cohen and al. et
Human Polymorphism Study Center (C.E.P.H.-Fondation Jean Dausset, Paris, France.

We have reported that 56% of French families with maturity-onset diabetes of the young (MODY) carry a mutation in the glucokinase gene (GCK). Therefore, we have established a quick and sensitive nonradioactive technique (with the PhastSystem based on single-strand conformation polymorphism [SSCP] analysis) to routinely screen the 12 exons of GCK for mutations. We have studied GCK in 12 young hyperglycemic patients with a strong family history of type II diabetes. SSCP variants were observed in 6 of those 12 patients (50%), which cosegregated with diabetes in five families where DNA from additional members was available. Direct sequencing identified a 10-bp (base pair) deletion in exon 3; a 33-bp deletion at the exon 5/intron 5 junction, including the two consensus bases (GT) of the donor splice site; a nonsense mutation in exon 5 (Arg186-->Stop) in a Black-African family, which has been identified previously in a Caucasian family; and three missense mutations: Thr209-->Met209 in exon 6, Gly261-->Glu261 in exon 7, and Arg36-->Trp36 in exon 2. The missense mutation in exon 2 was found only in the second and third generation of the tested family but not in the first. To our knowledge, this is the first time that a de novo mutation of GCK is reported within a family. All six families carrying a mutation in GCK were typical MODY and most of their affected members had a mild form of diabetes. This nonradioactive SSCP technique may be useful to routinely diagnose glucokinase deficiency, which is an important cause of hyperglycemia among young type II diabetic patients.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. L. Gloyn, E. A. Cummings, E. L. Edghill, L. W. Harries, R. Scott, T. Costa, I. K. Temple, A. T. Hattersley, and S. Ellard Permanent Neonatal Diabetes due to Paternal Germline Mosaicism for an Activating Mutation of the KCNJ11 Gene Encoding the Kir6.2 Subunit of the {beta}-Cell Potassium Adenosine Triphosphate Channel J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3932 - 3935. [Abstract] [Full Text] [PDF]

				S. Heikkinen, M. Pietila, M. Halmekyto, S. Suppola, E. Pirinen, S. S. Deeb, J. Janne, and M. Laakso Hexokinase II-deficient Mice. PRENATAL DEATH OF HOMOZYGOTES WITHOUT DISTURBANCES IN GLUCOSE TOLERANCE IN HETEROZYGOTES J. Biol. Chem., August 6, 1999; 274(32): 22517 - 22523. [Abstract] [Full Text] [PDF]

				C. Postic, M. Shiota, K. D. Niswender, T. L. Jetton, Y. Chen, J. M. Moates, K. D. Shelton, J. Lindner, A. D. Cherrington, and M. A. Magnuson Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic beta  Cell-specific Gene Knock-outs Using Cre Recombinase J. Biol. Chem., January 1, 1999; 274(1): 305 - 315. [Abstract] [Full Text] [PDF]